MRK

Merck & Co Inc

Oct 13 • 04:00PM ET

85.70

-0.29 -0.34 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE AZN NVS BMY JNJ AMGN ABBV GSK LLY SNY

| Held by: VTI VOO SCHD IVV SPY VTV XLV VIG VYM DGRO

Index	DJIA, S&P 500	P/E	13.21	EPS (ttm)	6.49	Insider Own	0.10%	Shs Outstand	2.50B	Perf Week	-3.49%
Market Cap	214.06B	Forward P/E	9.00	EPS next Y	9.52	Insider Trans	-0.17%	Shs Float	2.50B	Perf Month	3.49%
Enterprise Value	240.86B	PEG	1.24	EPS next Q	2.35	Inst Own	80.33%	Short Float	1.01%	Perf Quarter	5.13%
Income	16.41B	P/S	3.37	EPS this Y	16.41%	Inst Trans	-0.48%	Short Ratio	2.03	Perf Half Y	8.23%
Sales	63.43B	P/B	4.38	EPS next Y	6.88%	ROA	14.26%	Short Interest	25.17M	Perf YTD	-13.85%
Book/sh	19.57	P/C	24.70	EPS next 5Y	10.63%	ROE	35.44%	52W High	111.58 -23.19%	Perf Year	-22.28%
Cash/sh	3.47	P/FCF	14.54	EPS past 3/5Y	9.42% 12.04%	ROIC	19.78%	52W Low	73.31 16.90%	Perf 3Y	-1.99%
Dividend Est.	3.23 (3.77%)	EV/EBITDA	9.00	Sales past 3/5Y	9.36% 6.55%	Gross Margin	75.25%	Volatility	1.91% 2.37%	Perf 5Y	12.87%
Dividend TTM	3.24 (3.78%)	EV/Sales	3.80	EPS Y/Y TTM	20.01%	Oper. Margin	35.05%	ATR (14)	2.04	Perf 10Y	75.44%
Dividend Ex-Date	Sep 15, 2025	Quick Ratio	1.17	Sales Y/Y TTM	2.00%	Profit Margin	25.87%	RSI (14)	53.57	Recom	2.03
Dividend Gr. 3/5Y	5.73% 6.66%	Current Ratio	1.42	EPS Q/Q	-17.85%	SMA20	2.34%	Beta	0.34	Target Price	101.41
Payout	46.32%	Debt/Eq	0.72	Sales Q/Q	-2.20%	SMA50	2.63%	Rel Volume	0.53	Prev Close	85.99
Employees	75000	LT Debt/Eq	0.69	Earnings	Oct 30 BMO	SMA200	0.30%	Avg Volume	12.41M	Price	85.70
IPO	Jun 15, 1946	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.77% -0.37%	Trades		Volume	6,524,906	Change	-0.34%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-13-25	Resumed	Citigroup	Neutral	$95
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$90
May-14-25	Downgrade	Citigroup	Buy → Neutral	$84
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$85
Feb-18-25	Downgrade	Deutsche Bank	Buy → Hold	$128 → $105
Feb-10-25	Downgrade	TD Cowen	Buy → Hold	$121 → $100
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115
Oct-27-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$132
Oct-20-23	Upgrade	UBS	Neutral → Buy	$117 → $122
Jul-14-23	Initiated	HSBC Securities	Hold	$123
Apr-13-23	Upgrade	Citigroup	Neutral → Buy	$105 → $130

Show Previous Ratings

Oct-13-25 04:15PM	Top Stock Reports for Apple, Eli Lilly & Visa (Zacks)
12:12PM	2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk (MarketBeat)
12:10PM	Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:50AM	Here's Why Merck (MRK) is a Strong Momentum Stock (Zacks)
09:28AM	Merck Completes $10B Acquisition of Verona Pharma, Adds COPD Drug Ohtuvayre (Insider Monkey)
08:43AM	Loading…
08:43AM	Merck Initiates Three New Phase 2b Trials for Investigational Inflammatory Drug Tulisokibart (Insider Monkey)
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
Oct-10-25 11:57AM	Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings? (Zacks)
Oct-09-25 08:03AM	5 Healthcare Plays Powering the Sector's Big Comeback (MarketBeat)
07:00AM	Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025 (Business Wire)
06:45AM	Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025 (Business Wire)
Oct-08-25 09:28AM	Chart Expert Says Merck (MRK) Has More Upside - Here's Why (Insider Monkey)
08:50AM	Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings (Zacks)
08:42AM	3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal (Zacks)
01:49AM	Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks (Insider Monkey)
05:50PM	Loading…
Oct-07-25 05:50PM	Merck (MRK) Declines More Than Market: Some Information for Investors (Zacks)
04:03PM	How Arcus Biosciences Aims To Take On Merck In Cancer Treatment (Investor's Business Daily)
11:56AM	MRK Expands Tulisokibart Program in Three New Inflammatory Diseases (Zacks)
09:37AM	Gilead Resolves Patent Litigations for HIV Treatment Biktarvy (Zacks)
08:27AM	Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock? (Zacks)
06:45AM	Merck Completes Acquisition of Verona Pharma (Business Wire)
06:00AM	Hiltzik: There's much less than meets the eye in Trump's 'historic' drug price deal with Pfizer (LA Times)
Oct-06-25 11:33AM	Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. (Barrons.com)
09:03AM	Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk (Zacks)
06:45AM	Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases (Business Wire)
Oct-05-25 09:45AM	1 Monster Stock in the Making to Buy and Hold (Motley Fool)
02:42AM	Bernstein Maintains a Hold Rating on Merck & Co (MRK) (Insider Monkey)
Oct-03-25 04:55PM	5 Large Cap Drug Stocks: Values or Traps? (Zacks)
10:06AM	MRK Stock Up Nearly 14% So Far This Week: What's Driving It? (Zacks)
09:28AM	Pharma Stocks Eye Best Week in 16 Years as Trump Overhang Eases (Bloomberg)
06:28AM	Loading…
06:28AM	What Does Wall Street Think About Merck & Co. (MRK)? (Insider Monkey)
Oct-02-25 11:37AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
11:15AM	Can Novo Nordisk's Restructuring Program Drive its Return to Growth? (Zacks)
10:32AM	Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? (Zacks)
09:30AM	Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views? (Zacks)
09:00AM	Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? (Zacks)
03:28AM	Half of Mercks sales are in jeopardy. Can Keytrudas sequel save the day? (Pharma Voice)
02:55AM	Merck & Co (MRK) Announced Positive Results From Phase 3 HYPERION Trial of WINREVAIR (Insider Monkey)
Oct-01-25 05:36PM	Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial (Insider Monkey) +7.39%
04:55PM	Drug Stock Rally Helps Push Dow and S&P 500 to Records (The Wall Street Journal)
04:40PM	Stocks to Watch Wednesday: Meta, Netflix, Nike, Lithium Americas (The Wall Street Journal)
04:00PM	Why Merck (MRK) Stock Is Up Today (StockStory)
12:17PM	Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks (Yahoo Finance Video)
11:44AM	Pfizer Stock, Other Drugmakers Rally Again (The Wall Street Journal)
11:03AM	Q: Will TrumpRx and 'Most Favored Nation' Deals Save Americans Money? (The Wall Street Journal)
10:40AM	Can Relacorilant Drive Corcept's Long-Term Growth Beyond Korlym? (Zacks)
08:06AM	European healthcare stocks surge after US deal with Pfizer (Reuters Videos)
08:03AM	Big Pharma's big boost: Market Movers (Yahoo Finance Video)
08:01AM	How Fifth Third Bancorp, Merck, And Duke Energy Can Put Cash In Your Pocket (Benzinga)
Sep-30-25 05:14PM	Pfizer Stock Surges After Company Makes a Deal With President Trump (The Wall Street Journal) +6.81%
04:47PM	Pfizer Stock Soars on Trumps New Drug Pricing Plan. Heres Why. (Barrons.com)
04:26PM	S&P 500 Gains and Losses Today: Pfizer and Merck Jump; Payments Stocks Decline (Investopedia)
03:19PM	3 Pharma Stocks Getting an Intraday Trump Bump (Schaeffer's Research)
02:51PM	Merck (MRK) Shares Skyrocket, What You Need To Know (StockStory)
02:49PM	Bernstein Maintains a Hold Rating on Merck & Co. (MRK) (Insider Monkey)
01:31PM	Pfizer, Drug Stocks Leading S&P 500 on Pricing Deal with White House (Barrons.com)
11:47AM	Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs (The Wall Street Journal)
10:34AM	Pfizer, Other Drug Stocks Jump on Reports of Trump Pricing Plan (Barrons.com)
10:18AM	Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor? (Zacks)
06:30AM	Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus (The Daily Upside)
04:00AM	Merck & Co., Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development (Insider Monkey)
03:39AM	WINREVAIR (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial (Business Wire)
01:52AM	Big Pharmas retreat: Is NHS pricing behind investor pullbacks? (Euronews)
Sep-29-25 07:28AM	Genmab to acquire closely watched cancer drug in $8B Merus buyout (BioPharma Dive)
01:39AM	Merck (MRK) Announces Positive Recommendation from EU Medicines Agency (Insider Monkey)
Sep-28-25 06:42PM	Merck & Co., Inc. (MRK) Advances Oncology Pipeline with Breakthrough FDA Designation for Ovarian Cancer Drug (Insider Monkey)
Sep-26-25 05:45PM	Merck (MRK) Outperforms Broader Market: What You Need to Know (Zacks)
04:51PM	Eli Lilly, Pfizer, Amgen Stocks Rise After Trumps 100% Pharma Tariff Threat. Heres Why. (Barrons.com)
04:31PM	Stocks Close Higher After Trump Unveils New Tariffs (The Wall Street Journal)
02:11PM	Stocks Climb After Trump Unveils New Tariffs (The Wall Street Journal)
12:21PM	Stocks Rise After Trump Unveils New Tariffs (The Wall Street Journal)
11:48AM	Trump's 100% Drug Tariff Just Landed--Here's Why Wall Street Isn't Panicking (GuruFocus.com)
11:09AM	Merck's (MRK) Oncology Portfolio Gets Shot in the Arm with QLEX Nod (Insider Monkey)
09:58AM	Trump's new tariffs on pharma, furniture, & trucks: What to know (Yahoo Finance Video)
09:40AM	MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now? (Zacks)
09:14AM	Big pharma stocks rise as Street reacts to latest presidential tariff plan (Associated Press Finance)
08:15AM	Eli Lilly, Pfizer Stocks Rise After Trump's 100% Pharma Tariff Threat. Here's Why. (Barrons.com)
08:11AM	Analyst Highlights Growth Catalysts for Merck (MRK) Stock (Insider Monkey)
07:02AM	Eli Lilly, Merck, Pfizer Stocks Rise After Trump Unveils Pharma Tariffs (The Wall Street Journal)
07:02AM	Big Drugmakers Unfazed by Trump's New Pharma Tariffs (The Wall Street Journal)
03:17AM	Trump Plans New Tariff Push With 100% Rate on Patented Drugs (Bloomberg)
Sep-25-25 10:52PM	US, European pharma stocks steady after Trump's tariff move, Asia slips (Reuters)
12:35PM	MSD pays up to nearly $600m for Evaxions mystery vaccine candidate (Pharmaceutical Technology)
11:52AM	AstraZeneca Stock Rises 15% YTD: Should You Buy, Sell or Hold? (Zacks)
11:20AM	AZN, Daiichi's Enhertu sBLA Gets FDA Priority Review for Breast Cancer (Zacks)
09:40AM	Here's Why Merck (MRK) is a Strong Value Stock (Zacks)
07:17AM	Germanys Merck KGaA Names Kai Beckmann as Incoming Chair, CEO (The Wall Street Journal)
Sep-24-25 10:16AM	Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock? (Zacks)
07:45AM	The Smartest Dividend Stock to Buy With $1,000 Right Now (Motley Fool)
06:35AM	Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? (Motley Fool)
04:15AM	3 Dividend Stocks Perfect for Millennial Investors (Motley Fool)
04:11AM	Eli Lilly's boss calls UK the 'worst' European country for drug prices (Reuters)
Sep-23-25 07:41PM	Merck Gains FDA Approval for KEYTRUDA QLEX and Supports Dividend Appeal (Insider Monkey)
07:02PM	Merck & Co., Inc. (MRK) Received FDA Approval For Keytruda Qlex, Cutting Infusion Time to 2 Minutes (Insider Monkey)
11:57AM	AZN Gets CHMP Nod for Label Expansion of Koselugo & Tezspire (Zacks)
07:03AM	Merck and Siemens extend digital transformation partnership in life sciences (Pharmaceutical Technology)
04:54AM	FDA clears under-the-skin Keytruda; MBX shares double on study data (BioPharma Dive)
Sep-22-25 05:50PM	Merck (MRK) Stock Sinks As Market Gains: Here's Why (Zacks)
05:32PM	FDA Grants Breakthrough Therapy Designation to Merck & Co., Inc. (MRK)'s Raludotatug Deruxtecan for Platinum-Resistant Ovarian (Insider Monkey)
04:08PM	Merck Snags A Key Approval Before Its Cash Cow Goes Off A Patent Cliff (Investor's Business Daily)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Williams David Michael	EVP,Chief Info&Digital Officer	Aug 04 '25	Option Exercise	79.29	17,119	1,357,366	41,445	Aug 05 08:46 AM
Guindo Chirfi	Chief Marketing Officer	Aug 04 '25	Option Exercise	79.29	36,903	2,926,039	107,409	Aug 05 08:43 AM
Smart Dalton E. III	SVP Fin. - Global Controller	May 03 '25	Option Exercise	83.18	2,050	170,519	10,127	May 05 04:23 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 30 '25	Option Exercise	84.71	464	39,305	8,242	May 02 04:18 PM
Smart Dalton E. III	SVP Fin. - Global Controller	May 02 '25	Option Exercise	83.26	381	31,722	8,464	May 02 04:18 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '25	Option Exercise	83.26	2,262	188,334	24,061	May 02 04:14 PM
Romanelli Joseph	President, Human Health Int?l	Apr 30 '25	Option Exercise	84.71	2,063	174,757	22,816	May 02 04:14 PM
Larson Betty D	EVP, Chief HR Officer	Apr 30 '25	Option Exercise	84.71	11,350	961,458	11,350	May 02 04:12 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Option Exercise	58.08	5,000	290,400	12,040	Apr 29 04:04 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Sale	82.76	4,262	352,723	7,778	Apr 29 04:04 PM
DALTON SMART	Officer	Apr 25 '25	Proposed Sale	82.76	4,262	352,723		Apr 25 04:05 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 19 '25	Sale	84.09	8,500	714,745	30,705	Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 19 '25	Proposed Sale	84.09	8,500	714,745		Feb 19 05:09 PM
DAVID WILLIAMS	Officer	Feb 13 '25	Proposed Sale	85.34	6,000	512,057		Feb 13 04:10 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 13 '25	Sale	85.34	6,000	512,057	24,123	Feb 13 04:01 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 08 '25	Option Exercise	87.28	13,002	1,134,815	45,609	Feb 11 02:59 PM
THULIN INGE G	Director	Feb 06 '25	Buy	88.25	2,833	250,000	2,933	Feb 07 04:09 PM
Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Feb 06 '25	Sale	88.76	2,361	209,551	7,085	Feb 07 04:07 PM
BAKER DOUGLAS M JR	Director	Feb 05 '25	Buy	88.50	15,000	1,327,500	16,000	Feb 07 04:04 PM
CRISTAL DOWNING	Officer	Feb 06 '25	Proposed Sale	88.76	2,361	209,551		Feb 06 04:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRK

Merck & Co Inc

Upgrade your FINVIZ experience